Lumov Attracts INR 10 Cr Seed Funding to Strengthen Surgeon-Led MSK Product Innovation

The fresh capital will support product development and strengthen Lumov’s surgeon-led innovation pipeline.

Bengaluru-based orthopedic recovery and rehabilitation startup Lumov has secured a seed investment of INR 10 crore (USD 1.2 million) led by Incubate Fund Asia. The round also saw participation from QRG Investments and Holdings (Havells Family Office), IIMA Ventures, SIDBI, and several prominent angel investors, including Ashish Gupta of Helion Advisors, Saket Narang of Steinberg India, Abhishek Goyal of Tracxn, Arjun Vaidya, Indian Silicon Valley, Mapaex Family Office, and others.

The funding comes amid a rapid rise in musculoskeletal (MSK) disorders in India, driven by aging demographics, sedentary lifestyles, increasing orthopedic surgeries, and limited availability of clinically reliable recovery products. While the Indian medical devices market is expected to approach USD 50 billion by 2030, the orthotics and rehabilitation segment remains under-innovated, positioned between low-cost mass-market products and high-priced global imports. Lumov aims to address this gap by developing India-first MSK solutions rooted in clinical expertise and modern design principles.

The fresh capital will support product development and strengthen Lumov’s surgeon-led innovation pipeline. The investment will also enable expansion into Delhi NCR, Hyderabad, and Mumbai, scaling sales operations and boosting manufacturing capacity for post-surgical and rehabilitation-focused bracing solutions. Lumov currently has a 15-member core team, with plans for significant hiring as part of its growth roadmap.

Founded by Saumaric Dangwal and Ankit Gupta — alumni of IIT Kharagpur and Harvard Business School — Lumov draws on deep experience across healthcare, pharma, and consumer investing. Dangwal has previously worked with Bain Capital as a healthcare and consumer investor, while Gupta has been associated with Brookfield Private Equity and Steinberg Asset Management. Collectively, the founders have overseen more than USD 1.5 billion in investments across healthcare and allied sectors.

Commenting on the announcement, co-founders Saumaric Dangwal and Ankit Gupta said, “India is in the midst of an orthopaedic health crisis. While advances in diagnostics and care delivery are improving outcomes, we are building the physical product layer—premium, high-quality orthotics, rehabilitation aids, and pain-management solutions designed to accelerate recovery and help people live pain-free, active lives.”

Rajeev Ranka, Partner at Incubate Fund Asia, said the MSK category is primed for innovation and highlighted Lumov’s surgeon-led approach and design capabilities as key differentiators.

Ramesh Sharma, President of QRG Investments & Holdings, added that the founders’ clarity of vision and strong clinical partnerships position Lumov to build an integrated MSK products platform.

Stay tuned for more such updates on Digital Health News